TORCH Profile: A Convenient Method for Screening Infection in Pregnancy by ELISA: A Review
Klíčová slova:
TORCH, ELISA, IgG, IgMAbstrakt
TORCH is a medical acronym for a set of perinatal infections: toxoplasmosis, other (syphilis), rubella (German measles), cytomegalovirus (CMV), herpes simplex virus (HSV-1, 2). They are a group of viral, bacterial and protozoan infections that gain access to the fetal bloodstream transplacentally via the chorionic villi or hematogenous transmission any time during gestation or occasionally at the time of delivery via maternal-to-fetal transfusion. TORCH infections may result in abortion, still birth, premature birth, growth problems, neurological or brain abnormalities, motor problems, cognitive problems, organ damage or chronic illness. Among the different direct and indirect methods available for the detection of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies against each test of TORCH panel, indirect ELISA is one of the most convenient methods. Positive IgG is indicative of previous infection or immunization whereas positive IgM is indicative of active or recent infection. Negative results indicate no detectable level of antibodies and equivocal result may occur during acute infection or due to nonspecific binding reaction. From the results of different studies on TORCH, it is concluded that all antenatal cases with bad obstetrics history should be routinely screened for TORCH for early diagnosis as appropriate intervention at early stages can help in proper management of probable complications. Keywords: TORCH, ELISA, IgG, IgMPublikováno
Číslo
Sekce
Licence
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |